ID   NUDT5_HUMAN             Reviewed;         219 AA.
AC   Q9UKK9; A8K516; Q6IAG0; Q9UH49;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-JUL-2015, entry version 138.
DE   RecName: Full=ADP-sugar pyrophosphatase;
DE            EC=3.6.1.13;
DE   AltName: Full=8-oxo-dGDP phosphatase;
DE            EC=3.6.1.58;
DE   AltName: Full=Nucleoside diphosphate-linked moiety X motif 5;
DE            Short=Nudix motif 5;
DE   AltName: Full=YSA1H;
GN   Name=NUDT5; ORFNames=HSPC115;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RX   PubMed=10567213; DOI=10.1042/0264-6021:3440331;
RA   Gasmi L., Cartwright J.L., McLennan A.G.;
RT   "Cloning, expression and characterization of YSA1H, a human adenosine
RT   5'-diphosphosugar pyrophosphatase possessing a MutT motif.";
RL   Biochem. J. 344:331-337(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RX   PubMed=10722730; DOI=10.1074/jbc.275.12.8844;
RA   Yang H., Slupska M.M., Wei Y.-F., Tai J.H., Luther W.M., Xia Y.-R.,
RA   Shih D.M., Chiang J.-H., Baikalov C., Fitz-Gibbon S., Phan I.T.,
RA   Conrad A., Miller J.H.;
RT   "Cloning and characterization of a new member of the Nudix hydrolases
RT   from human and mouse.";
RL   J. Biol. Chem. 275:8844-8853(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for
RT   300 previously undefined genes expressed in CD34+ hematopoietic
RT   stem/progenitor cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-74, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-210 AND LYS-218, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-10, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-3, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1-210 IN COMPLEX WITH AMP;
RP   MAGNESIUM IONS AND ADP-RIBOSE, FUNCTION, CATALYTIC ACTIVITY, SUBUNIT,
RP   AND COFACTOR.
RX   PubMed=17052728; DOI=10.1016/j.jmb.2006.09.078;
RA   Zha M., Zhong C., Peng Y., Hu H., Ding J.;
RT   "Crystal structures of human NUDT5 reveal insights into the structural
RT   basis of the substrate specificity.";
RL   J. Mol. Biol. 364:1021-1033(2006).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1-210 IN COMPLEX WITH AMPCPR
RP   AND MAGNESIUM IONS, COFACTOR, MUTAGENESIS OF TRP-28; TRP-46; ARG-51;
RP   ARG-84; LEU-98; GLU-112; GLU-116 AND GLU-166, AND SUBUNIT.
RX   PubMed=18462755; DOI=10.1016/j.jmb.2008.04.006;
RA   Zha M., Guo Q., Zhang Y., Yu B., Ou Y., Zhong C., Ding J.;
RT   "Molecular mechanism of ADP-ribose hydrolysis by human NUDT5 from
RT   structural and kinetic studies.";
RL   J. Mol. Biol. 379:568-578(2008).
CC   -!- FUNCTION: Hydrolyzes with similar activities ADP-ribose ADP-
CC       mannose, ADP-glucose, 8-oxo-GDP and 8-oxo-dGDP. Can also hydrolyze
CC       other nucleotide sugars with low activity. Does not play a role in
CC       U8 snoRNA decapping activity. Binds U8 snoRNA.
CC       {ECO:0000269|PubMed:17052728}.
CC   -!- CATALYTIC ACTIVITY: ADP-D-ribose + H(2)O = AMP + D-ribose 5-
CC       phosphate. {ECO:0000269|PubMed:17052728}.
CC   -!- CATALYTIC ACTIVITY: ADP-sugar + H(2)O = AMP + alpha-D-aldose 5-
CC       phosphate. {ECO:0000269|PubMed:17052728}.
CC   -!- CATALYTIC ACTIVITY: 8-oxo-dGDP + H(2)O = 8-oxo-dGMP + phosphate.
CC       {ECO:0000269|PubMed:17052728}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:17052728,
CC         ECO:0000269|PubMed:18462755};
CC       Note=Binds 3 Mg(2+) ions per subunit.
CC       {ECO:0000269|PubMed:17052728, ECO:0000269|PubMed:18462755};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:17052728,
CC       ECO:0000269|PubMed:18462755}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. Most abundant in liver.
CC   -!- SIMILARITY: Belongs to the Nudix hydrolase family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 nudix hydrolase domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00794}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF155832; AAF06734.1; -; mRNA.
DR   EMBL; AF218818; AAF25479.1; -; mRNA.
DR   EMBL; AF161464; AAF29079.1; -; mRNA.
DR   EMBL; CR457195; CAG33476.1; -; mRNA.
DR   EMBL; AK291131; BAF83820.1; -; mRNA.
DR   EMBL; CH471072; EAW86322.1; -; Genomic_DNA.
DR   EMBL; BC000025; AAH00025.1; -; mRNA.
DR   CCDS; CCDS7089.1; -.
DR   RefSeq; NP_054861.2; NM_014142.2.
DR   UniGene; Hs.555956; -.
DR   PDB; 2DSB; X-ray; 2.50 A; A/B/C/D=1-219.
DR   PDB; 2DSC; X-ray; 2.00 A; A/B=1-210.
DR   PDB; 2DSD; X-ray; 2.60 A; A/B=1-210.
DR   PDB; 3AC9; X-ray; 2.10 A; A/B=14-208.
DR   PDB; 3ACA; X-ray; 2.05 A; A/B=13-208.
DR   PDB; 3BM4; X-ray; 2.00 A; A/B=1-210.
DR   PDB; 3L85; X-ray; 2.30 A; A/B=14-208.
DR   PDBsum; 2DSB; -.
DR   PDBsum; 2DSC; -.
DR   PDBsum; 2DSD; -.
DR   PDBsum; 3AC9; -.
DR   PDBsum; 3ACA; -.
DR   PDBsum; 3BM4; -.
DR   PDBsum; 3L85; -.
DR   ProteinModelPortal; Q9UKK9; -.
DR   SMR; Q9UKK9; 13-209.
DR   BioGrid; 116335; 13.
DR   IntAct; Q9UKK9; 7.
DR   MINT; MINT-1370495; -.
DR   STRING; 9606.ENSP00000419628; -.
DR   PhosphoSite; Q9UKK9; -.
DR   BioMuta; NUDT5; -.
DR   MaxQB; Q9UKK9; -.
DR   PaxDb; Q9UKK9; -.
DR   PRIDE; Q9UKK9; -.
DR   DNASU; 11164; -.
DR   Ensembl; ENST00000491614; ENSP00000419628; ENSG00000165609.
DR   Ensembl; ENST00000537776; ENSP00000445116; ENSG00000165609.
DR   GeneID; 11164; -.
DR   KEGG; hsa:11164; -.
DR   UCSC; uc001ilj.3; human.
DR   CTD; 11164; -.
DR   GeneCards; GC10M012207; -.
DR   HGNC; HGNC:8052; NUDT5.
DR   HPA; HPA019827; -.
DR   MIM; 609230; gene.
DR   neXtProt; NX_Q9UKK9; -.
DR   PharmGKB; PA31838; -.
DR   eggNOG; COG0494; -.
DR   GeneTree; ENSGT00390000006280; -.
DR   HOGENOM; HOG000174302; -.
DR   HOVERGEN; HBG052691; -.
DR   InParanoid; Q9UKK9; -.
DR   KO; K13987; -.
DR   OrthoDB; EOG7CVPZW; -.
DR   PhylomeDB; Q9UKK9; -.
DR   TreeFam; TF106347; -.
DR   BRENDA; 3.6.1.13; 2681.
DR   BRENDA; 3.6.1.58; 2681.
DR   Reactome; REACT_150237; Phosphate bond hydrolysis by NUDT proteins.
DR   SABIO-RK; Q9UKK9; -.
DR   ChiTaRS; NUDT5; human.
DR   EvolutionaryTrace; Q9UKK9; -.
DR   GeneWiki; NUDT5; -.
DR   GenomeRNAi; 11164; -.
DR   NextBio; 42475; -.
DR   PRO; PR:Q9UKK9; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; Q9UKK9; -.
DR   CleanEx; HS_NUDT5; -.
DR   ExpressionAtlas; Q9UKK9; baseline and differential.
DR   Genevisible; Q9UKK9; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005622; C:intracellular; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0047631; F:ADP-ribose diphosphatase activity; EXP:Reactome.
DR   GO; GO:0019144; F:ADP-sugar diphosphatase activity; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0017110; F:nucleoside-diphosphatase activity; IEA:Ensembl.
DR   GO; GO:0030515; F:snoRNA binding; ISS:UniProtKB.
DR   GO; GO:0019303; P:D-ribose catabolic process; NAS:UniProtKB.
DR   GO; GO:0034656; P:nucleobase-containing small molecule catabolic process; TAS:Reactome.
DR   GO; GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome.
DR   GO; GO:0009117; P:nucleotide metabolic process; NAS:ProtInc.
DR   GO; GO:0009191; P:ribonucleoside diphosphate catabolic process; IDA:UniProtKB.
DR   GO; GO:0044281; P:small molecule metabolic process; TAS:Reactome.
DR   Gene3D; 3.90.79.10; -; 1.
DR   InterPro; IPR020476; Nudix_hydrolase.
DR   InterPro; IPR020084; NUDIX_hydrolase_CS.
DR   InterPro; IPR000086; NUDIX_hydrolase_dom.
DR   InterPro; IPR015797; NUDIX_hydrolase_dom-like.
DR   Pfam; PF00293; NUDIX; 1.
DR   PRINTS; PR00502; NUDIXFAMILY.
DR   SUPFAM; SSF55811; SSF55811; 1.
DR   PROSITE; PS51462; NUDIX; 1.
DR   PROSITE; PS00893; NUDIX_BOX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Hydrolase; Magnesium;
KW   Metal-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   RNA-binding.
FT   CHAIN         1    219       ADP-sugar pyrophosphatase.
FT                                /FTId=PRO_0000057048.
FT   DOMAIN       57    197       Nudix hydrolase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00794}.
FT   REGION       46     47       Substrate binding; shared with dimeric
FT                                partner.
FT   MOTIF        97    118       Nudix box.
FT   METAL        96     96       Magnesium 1; via carbonyl oxygen.
FT   METAL       112    112       Magnesium 2.
FT   METAL       112    112       Magnesium 3.
FT   METAL       116    116       Magnesium 1.
FT   METAL       116    116       Magnesium 3.
FT   METAL       166    166       Magnesium 3.
FT   BINDING      28     28       Substrate.
FT   BINDING      51     51       Substrate; shared with dimeric partner.
FT   BINDING      84     84       Substrate.
FT   BINDING      98     98       Substrate; via amide nitrogen.
FT   BINDING     133    133       Substrate.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000269|PubMed:19413330,
FT                                ECO:0000269|PubMed:20068231,
FT                                ECO:0000269|PubMed:21406692,
FT                                ECO:0000269|PubMed:22223895}.
FT   MOD_RES       3      3       Phosphoserine.
FT                                {ECO:0000269|PubMed:21406692}.
FT   MOD_RES      10     10       Phosphoserine.
FT                                {ECO:0000269|PubMed:20068231}.
FT   MOD_RES      74     74       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:15592455}.
FT   MOD_RES     210    210       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:19608861}.
FT   MOD_RES     218    218       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:19608861}.
FT   VARIANT     123    123       I -> T (in dbSNP:rs34863826).
FT                                /FTId=VAR_034159.
FT   MUTAGEN      28     28       W->A: Reduces affinity for substrate
FT                                about 8-fold. Strongly reduced catalytic
FT                                activity and strongly reduced affinity
FT                                for substrate; when associated with A-46.
FT                                {ECO:0000269|PubMed:18462755}.
FT   MUTAGEN      46     46       W->A: Reduces affinity for substrate
FT                                about 6-fold. Strongly reduced catalytic
FT                                activity and strongly reduced affinity
FT                                for substrate; when associated with A-28.
FT                                {ECO:0000269|PubMed:18462755}.
FT   MUTAGEN      51     51       R->Q: Reduces affinity for substrate
FT                                about 15-fold and reduces catalytic rate
FT                                about 17-fold.
FT                                {ECO:0000269|PubMed:18462755}.
FT   MUTAGEN      84     84       R->Q: Reduces affinity for substrate
FT                                about 5-fold and reduces catalytic rate
FT                                67-fold. {ECO:0000269|PubMed:18462755}.
FT   MUTAGEN      98     98       L->A: Reduces affinity for substrate
FT                                about 6-fold.
FT                                {ECO:0000269|PubMed:18462755}.
FT   MUTAGEN     112    112       E->Q: Reduces catalytic rate 6300-fold.
FT                                {ECO:0000269|PubMed:18462755}.
FT   MUTAGEN     116    116       E->Q: Reduces catalytic rate 2000-fold.
FT                                {ECO:0000269|PubMed:18462755}.
FT   MUTAGEN     166    166       E->Q: Reduces catalytic rate 120-fold.
FT                                {ECO:0000269|PubMed:18462755}.
FT   CONFLICT     50     52       KRT -> NVP (in Ref. 2; AAF25479).
FT                                {ECO:0000305}.
FT   STRAND       16     25       {ECO:0000244|PDB:2DSC}.
FT   STRAND       27     37       {ECO:0000244|PDB:2DSC}.
FT   STRAND       43     51       {ECO:0000244|PDB:2DSC}.
FT   STRAND       60     69       {ECO:0000244|PDB:2DSC}.
FT   STRAND       76     84       {ECO:0000244|PDB:2DSC}.
FT   HELIX        85     87       {ECO:0000244|PDB:2DSC}.
FT   STRAND       89     93       {ECO:0000244|PDB:2DSC}.
FT   STRAND       96     98       {ECO:0000244|PDB:2DSC}.
FT   HELIX       105    117       {ECO:0000244|PDB:2DSC}.
FT   STRAND      122    126       {ECO:0000244|PDB:2DSC}.
FT   STRAND      130    132       {ECO:0000244|PDB:2DSC}.
FT   TURN        134    136       {ECO:0000244|PDB:2DSC}.
FT   STRAND      140    149       {ECO:0000244|PDB:2DSC}.
FT   HELIX       153    155       {ECO:0000244|PDB:2DSC}.
FT   STRAND      164    166       {ECO:0000244|PDB:3AC9}.
FT   STRAND      169    174       {ECO:0000244|PDB:2DSC}.
FT   HELIX       175    177       {ECO:0000244|PDB:2DSC}.
FT   HELIX       178    189       {ECO:0000244|PDB:2DSC}.
FT   STRAND      192    194       {ECO:0000244|PDB:2DSC}.
FT   HELIX       195    207       {ECO:0000244|PDB:2DSC}.
FT   TURN        211    213       {ECO:0000244|PDB:2DSB}.
FT   HELIX       214    216       {ECO:0000244|PDB:2DSB}.
SQ   SEQUENCE   219 AA;  24328 MW;  6574E0BF1EA2BB26 CRC64;
     MESQEPTESS QNGKQYIISE ELISEGKWVK LEKTTYMDPT GKTRTWESVK RTTRKEQTAD
     GVAVIPVLQR TLHYECIVLV KQFRPPMGGY CIEFPAGLID DGETPEAAAL RELEEETGYK
     GDIAECSPAV CMDPGLSNCT IHIVTVTING DDAENARPKP KPGDGEFVEV ISLPKNDLLQ
     RLDALVAEEH LTVDARVYSY ALALKHANAK PFEVPFLKF
//
